European Journal of Nuclear Medicine and Molecular Imaging ( IF 8.6 ) Pub Date : 2024-11-22 , DOI: 10.1007/s00259-024-06993-3 Weiyi Wang, Yanru Wang, Limin Xu, Xueling Liu, Yuqing Hu, Junpeng Li, Qi Huang, Shuhua Ren, Yiyun Huang, Yihui Guan, Yuxin Li, Fengchun Hua, Qing Ye, Fang Xie
Objective
To investigate the relationship of synaptic loss with glucose metabolism and dopaminergic transporters in Parkinson’s disease (PD) patients.
Methods
A total of 16 patients with PD and 11 age-matched healthy controls underwent positron emission tomography (PET) with the tracers [18F]SynVesT-1, a ligand for the presynaptic terminal marker synaptic vesicle protein 2 A (SV2A), and FDG. PD patients also underwent PET with the dopamine transporter (DAT) ligand [18F]FP-CIT. The difference in synaptic density between PD patients and age-matched normal controls(NCs) was determined in the selected regions of interest, and the correlations of the [18F]SynVesT-1 PET SUVRs with [18F]FP-CIT PET SUVRs and [18F]FDG PET SUVRs were evaluated.
Results
Compared with that in the NC group, the synaptic density in the caudate region was significantly lower in the PD group (SUVR: 2.51 ± 0.36 vs. 3.18 ± 0.32, p < 0.001), especially in the pre-commissural caudate and post-commissural caudate (SUVR: 2.42 ± 0.29 vs. 2.63 ± 0.32, p < 0.01; 0.76 ± 0.31 vs. 0.97 ± 0.33, p < 0.001). A reduced synaptic density was significantly correlated with DAT (r = 0.61, p < 0.001) and glucose metabolism (r = 0.73, p < 0.001) in the post-commissural caudate. In the post-commissural regions of the caudate, there was a partial mediating effect of synaptic density on the relationship between glucose metabolism and DAT availability (indirect effect: β4 = 0.039, p = 0.024).
Conclusion
[18F]SynVesT-1 binds specifically to SV2A, reflecting synaptic density, and there is a positive correlation metabolic pattern related to the changes reflected by [18F]SynVesT-1 and [18F]FDG.
中文翻译:
帕金森病患者的突触前末梢完整性与葡萄糖代谢有关
目的
探讨帕金森病 (PD) 患者突触丢失与葡萄糖代谢和多巴胺能转运蛋白的关系。
方法
共有 16 名 PD 患者和 11 名年龄匹配的健康对照者接受了示踪剂 [18F]SynVesT-1 的正电子发射断层扫描 (PET),示踪剂是突触前末端标志物突触囊泡蛋白 2 A (SV2A) 和 FDG 的配体。PD 患者还接受了多巴胺转运蛋白 (DAT) 配体 [18F]FP-CIT 的 PET。在选定的感兴趣区域确定 PD 患者与年龄匹配的正常对照 (NCs) 之间的突触密度差异,并评估 [18F]SynVesT-1 PET SUVRs 与 [18F]FP-CIT PET SUVRs 和 [18F]FDG PET SUVRs 的相关性。
结果
与 NC 组相比,PD 组尾状核区的突触密度显著降低(SUVR:2.51 ± 0.36 vs. 3.18 ± 0.32,p < 0.001),尤其是在尾状结前尾状 核和尾状结后(SUVR:2.42 ± 0.29 对 2.63 ± 0.32,p < 0.01;0.76 ± 0.31 对 0.97 ± 0.33,p < 0.001)。 突触密度降低与尾状核后 DAT (r = 0.61,p % 3C 0.001) 和葡萄糖代谢 (r = 0.73,p < 0.001) 显著相关。 在尾状核的连合后区域,突触密度对葡萄糖代谢和 DAT 可用性之间的关系存在部分介导作用 (间接效应: β4 = 0.039,p = 0.024)。
结论
[18个地址]SynVesT-1 与 SV2A 特异性结合,反映突触密度,并且与 [18F]SynVesT-1 和 [18F]FDG 反映的变化呈正相关代谢模式。